TGF-β inhibits IL-2 production and promotes cell cycle arrest in TCR-activated effector/memory T cells in the presence of sustained TCR signal transduction

被引:58
作者
Das, Lopamudra [1 ]
Levine, Alan D. [1 ,2 ,3 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Pathol & Pharmacol, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
关键词
GROWTH-FACTOR-BETA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INTESTINAL EPITHELIAL-CELLS; INFLAMMATORY-BOWEL-DISEASE; TRANSFORMING GROWTH-FACTOR-BETA-1; ALLERGIC ENCEPHALOMYELITIS; TYROSINE PHOSPHATASES; GENE-EXPRESSION; CROHNS-DISEASE; POTENTIAL ROLE;
D O I
10.4049/jimmunol.180.3.1490
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
TGF-beta signaling is critical for controlling naive T cell homeostasis and differentiation; however, the biological and biochemical changes induced by TGF-beta in effector/memory T cells are poorly defined. We show that although TGF-beta inhibits effector/memory peripheral blood T lymphoblast proliferation and IL-2 production, the intensity and kinetics for TCR-induced global tyrosine phosphorylation are markedly increased compared with that in untreated cells or naive T cells. After TCR ligation, tyrosine phosphorylation of proximal tyrosine kinases and docking proteins like linker for activation of T cells is maintained for > 30 min in TGF-beta-primed cells compared with untreated cells where phosphorylation of these targets returned to basal levels by 10 min. Extended phosphorylation of linker for activation of T cells in treated peripheral blood T selectively prolongs ERK 1/2 signaling and phospholipase C-gamma 1 activation leading to increased Ca(2+) flux. A kinase/phosphatase imbalance could not account for extended phosphorylation as CD45R, SHP-1, and SHP-2 expression remains unaltered. The contradiction between prolonged signal transduction and inhibition of proliferation is partially explained by the observation that TGF-beta priming results in ERK 1/2-independent p21 induction and decreased cyclin D1 expression leading,to accumulation of T cells in G(0)/G(1) phases of the cell cycle and cell cycle arrest. Despite inhibition of T cell function by TGF-beta priming, TCR and cytokine signaling pathways are intact and selectively extended, suggesting that suppression in the effector/memory T cell is mediated by reprogramming signal transduction, rather than its inhibition as in the naive T cell.
引用
收藏
页码:1490 / 1498
页数:9
相关论文
共 63 条
[11]
Complementary role of CD4+CD25+ regulatory T cells and TGF-β in oral tolerance [J].
Chung, Y ;
Lee, SH ;
Kim, DH ;
Kang, CY .
JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 77 (06) :906-913
[12]
Involvement of the ERK signaling cascade in protein kinase C-mediated cell cycle arrest in intestinal epithelial cells [J].
Clark, JA ;
Black, AR ;
Leontieva, OV ;
Frey, MR ;
Pysz, MA ;
Kunneva, L ;
Woloszynska-Read, A ;
Roy, D ;
Black, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (10) :9233-9247
[13]
Integration of T cell receptor-dependent signaling pathways by adapter proteins [J].
Clements, JL ;
Boerth, NJ ;
Lee, JR ;
Koretzky, GA .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :89-108
[14]
Epithelia: lymphocyte interactions in the gut [J].
Dahan, Stephanie ;
Roth-Walter, Franziska ;
Arnaboldi, Paul ;
Agarwal, Shradha ;
Mayer, Lloyd .
IMMUNOLOGICAL REVIEWS, 2007, 215 :243-253
[15]
DIFFERENTIAL EFFECT OF TRANSFORMING GROWTH-FACTOR-BETA-1 ON THE ACTIVATION OF HUMAN NAIVE AND MEMORY CD4(+) T-LYMPHOCYTES [J].
DEJONG, R ;
VANLIER, RAW ;
RUSCETTI, FW ;
SCHMITT, C ;
DEBRE, P ;
MOSSALAYI, MD .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (04) :631-638
[16]
Microtubule binding to Smads may regulate TGFβ activity [J].
Dong, CM ;
Li, ZR ;
Alvarez, R ;
Feng, XH ;
Goldschmidt-Clermont, PJ .
MOLECULAR CELL, 2000, 5 (01) :27-34
[17]
Distinct pathways involving the FK506-binding proteins 12 and 12.6 underlie IL-2-versus IL-15-mediated proliferation of T cells [J].
Dubois, S ;
Shou, WN ;
Haneline, LS ;
Fleischer, S ;
Waldmann, TA ;
Müller, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14169-14174
[19]
Faria Ana M. C., 2006, Inflammation & Allergy Drug Targets, V5, P179
[20]
Fuss IJ, 1996, J IMMUNOL, V157, P1261